Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet

Kidney Research and Clinical Practice

Volumn 33, Issue 1, 2014, Pages 33-44

  Min, Hye Sook ^a   Kim, Jung Eun ^a   Lee, Mi Hwa ^a   Song, Hye Kyoung ^a   Lee, Mi Jin ^a   Lee, Ji Eun ^b   Kim, Hyun Wook ^b   Cha, Jin Joo ^a   Hyun, Young Youl ^c   Han, Jee Young ^d   Cha, Dae Ryong ^a   Kang, Young Sun ^a  

^a Korea University College of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Inha University School of Medicine   (South Korea)

Author keywords

Kidney disease; Metabolic syndrome; Obesity; Toll like receptors

Indexed keywords

4,5 DIHYDRO 3 PHENYL 5 ISOXASOLE ACETIC ACID; CHOLESTEROL; GAMMA INTERFERON; GIT 27; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF LIPID METABOLISM; DRUG ACTIVITY; DRUG EFFECT; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; GENE EXPRESSION; GLUCOSE INTOLERANCE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIPID PEROXIDATION; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY RELATED KIDNEY DISEASE; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTEINURIA; RENAL PROTECTION; SIGNAL TRANSDUCTION;

EID: 84897442643     PISSN: 22119132     EISSN: 22119140     Source Type: Journal    
DOI: 10.1016/j.krcp.2013.11.002     Document Type: Article

References (34)

1. M. Cignarelli, and O. Lamacchia Obesity and kidney disease Nutr Metab Cardiovasc Dis 17 2007 757 762
2. Y.S. Kang, J.J. Cha, Y.Y. Hyun, D.R. Cha, and C.-C. Novel chemokine receptor 2 antagonists in metabolic disease: a review of recent developments Expert Opin Investig Drugs 20 2011 745 756
3. C. Wickman, and H. Kramer Obesity and kidney disease: potential mechanisms Semin Nephrol 33 2013 14 22
4. K. Amann, and K. Benz Structural renal changes in obesity and diabetes Semin Nephrol 33 2013 23 33
5. S.C. Kang, B.R. Kim, S.Y. Lee, and T.S. Park Sphingolipid metabolism and obesity-induced inflammation Front Endocrinol 4 2013 1 11
6. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
7. H. Kwon, and J.E. Pessin Adipokines mediate inflammation and insulin resistance Front Endocrinol 4 2013 1 13
8. D. Tripathy, P. Mohanty, S. Dhindsa, T. Syed, H. Ghanim, A. Aljada, and P. Dandona Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects Diabetes 52 2003 2882 2887
9. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 116 2006 3015 3025
10. J.Y. Lee, K.H. Sohn, S.H. Rhee, and D. Hwang Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4 J Biol Chem 276 2001 16683 16689
11. K. Takeda, and S. Akira TLR signaling pathways Semin Immunol 16 2004 3 9
12. C. Zuany-Amorim, J. Hastewell, and C. Walker Toll-like receptors as potential therapeutic targets for multiple diseases Nat Rev Drug Discov 1 2002 797 807
13. H. Wu, G. Chen, K.R. Wyburn, J. Yin, P. Bertolino, J.M. Eris, S.I. Alexander, A.F. Sharland, and S.J. Chadban TLR4 activation mediates kidney ischemia/reperfusion injury J Clin Invest 117 2007 2847 2859
14. P.N. Cunningham, Y. Wang, R. Guo, G. He, and R.J. Quigg Role of Toll-like receptor 4 in endotoxin-induced acute renal failure J Immunol 172 2004 2629 2635
15. D.R. Goldstein, B.M. Tesar, S. Akira, and F.G. Lakkis Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection J Clin Invest 111 2003 1571 1578
16. B. Liu, Y. Yang, J. Dai, R. Medzhitov, M.A. Freudenberg, P.L. Zhang, and Z. Li TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease J Immunol 177 2006 6880 6888
17. H.J. Brown, H.R. Lock, T.G. Wolfs, W.A. Buurman, S.H. Sacks, and M.G. Robson Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2 J Am Soc Nephrol 18 2007 1732 1739
18. J.J. Cha, Y.Y. Hyun, M.H. Lee, J.E. Kim, D.H. Nam, H.K. Song, Y.S. Kang, J.E. Lee, H.W. Kim, J.Y. Han, and D.R. Cha Renal protective effects of Toll-like receptor 4 signaling blockade in type 2 diabetic mice Endocrinology 154 2013 2144 2155
19. S. Stosic-Grujicic, I. Cvetkovic, K. Mangano, M. Fresta, D. Maksimovic-Ivanic, L. Harhaji, D. Popadic, M. Momcilovic, D. Miljkovic, J. Kim, Y. Al-Abed, and F. Nicoletti A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in nod mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice J Pharmacol Exp Ther 320 2007 1038 1049
20. I. Stojanovic, S. Cuzzocrea, K. Mangano, E. Mazzon, D. Miljkovic, M. Wang, M. Donia, Y. Al Abed, J. Kim, F. Nicoletti, S. Stosic-Grujicic, and M. Claesson In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: Modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models Clin Immunol 123 2007 311 323
21. K. Mangano, N. Sardesai, M. D'Alcamo, M. Libra, L. Malaguarnera, M. Donia, K. Bendtzen, P. Meroni, and F. Nicoletti In vitro inhibition of enterobacteria-reactive CD4+CD25-T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027 Eur J Pharmacol 586 2008 313 321
22. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 1959 911 917
23. M.H. Lee, H.K. Song, G.J. Ko, Y.S. Kang, S.Y. Han, K.H. Han, H.K. Kim, J.Y. Han, and D.R. Cha Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue Kidney Int 74 2008 890 900
24. S.Y. Han, Y.S. Kang, Y.H. Jee, K.H. Han, D.R. Cha, S.W. Kang, and D.S. Han High glucose and angiotensin ll increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes Cell Tissue Res 323 2006 321 332
25. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 adipocytes FEBS Lett 500 2001 60 63
26. M.R. Dasu, and I. Jialal Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors Am J Physiol Endocrinol Metab 300 2011 E145 E154
27. J. Sieber, M.T. Lindenmeyer, K. Kampe, K.N. Campbell, C.D. Cohen, H. Hopfer, P. Mundel, and A.W. Jehle Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids Am J Physiol Renal Physiol 299 2010 F821 F829
28. T.J. Guzik, D. Mangalat, and R. Korbut Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol 57 2006 505 528
29. F. Lago, C. Dieguez, J. Gomez-Reino, and O. Gualillo Adipokines as emerging mediators of immune response and inflammation Nat Clin Pract 3 2007 716 724
30. Y. Nagai, Y. Watanabe, and K. Takatsu The TLR family protein RP105/MD-1 complex: a new player in obesity and adipose tissue inflammation Adipocyte 2 2013 61 66
31. A. Majdalawieh, and H.S. Ro Regulation of IκBα function and NF-κB signaling: AEBP1 is a novel proinflammatory mediator in macrophages Mediators Inflamm 823821 2010 1 27
32. A. Schaffler, and J. Scholmerich Innate immunity and adipose tissue biology Trends Immunol 31 2010 228 235
33. B.A. Young, R.J. Johnson, C.E. Alpers, E. Eng, K. Gordon, J. Floege, W.G. Couser, and K. Seidel Cellular events in the evolution of experimental diabetic nephropathy Kidney Int 47 1995 935 944
34. M. Lin, W.H. Yiu, R.X. Li, H.J. Wu, D.W. Wong, L.Y. Chan, J.C. Leung, K.N. Lai, and S.C. Tang The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy Kidney Int 83 2013 887 900